Literature DB >> 7966387

The limited precision of phase I trials.

M C Christian, E L Korn.   

Abstract

Mesh：

Substances：

Year:  1994        PMID： 7966387     DOI： 10.1093/jnci/86.22.1662

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN： 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  2 in total

1.  Proposal for size justification of expanded cohort at phase-2-recommended dose.

Authors:  Nicolas Penel; Charles Fournier; Jocelyne Bérille
Journal:  Invest New Drugs       Date:  2010-02-02       Impact factor: 3.850

2.  Nature and subjectivity of dose-limiting toxicities in contemporary phase 1 trials: comparison of cytotoxic versus non-cytotoxic drugs.

Authors:  Nicolas Penel; Antoine Adenis; Stéphanie Clisant; Jacques Bonneterre
Journal:  Invest New Drugs       Date:  2010-07-09       Impact factor: 3.651
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.